Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SANGUINE CORP. (SGNC) -- Ignore unavailable to you. Want to Upgrade?

To: chirodoc who wrote (1546)	6/21/1998 5:52:00 PM
From: Little Engine	Read Replies (2) \| Respond to of 5402

As I said, "existing market." Without FDA approval, the product could not be used on a widespread basis. As you noted, Oxygent has been used in clinical trials on actual human beings. SGNC's product has not reached the animal testing stage yet. I don't doubt there is a wide need for the product. But when will that product be developed? How much longer after that will the FDA approved it? Most importantly, how long will SGNC take to catch up to Alliance Pharmeceutical?